Article
Broad spectrum compounds targeting early stages of rabies virus (RABV) infection.
Antiviral research - 1 Apr 2021
Kali Sabrina, Jallet Corinne, Azebi Saliha, Cokelaer Thomas, Da Fonseca Juliana Pipoli, Wu Yu, Barbier Julien, Cintrat Jean-Christophe, Gillet Daniel, Tordo Noël
Abstract excerpt
ABMA and its analogue DABMA are two molecules of the adamantane family known to perturbate the endosomal pathway and to inhibit cell infection of several RNA and DNA viruses. Their activity against Rabies Virus (RABV) infection has already been demonstrated in vitro. (Wu et al., 2017, 2019). Here, we describe in more details their mechanism of action by comparison to Arbidol (umifenovir) and Ribavirin, two broad...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
